(DNA sequencing vs. protein detection). Although the same G-rich bias upstream of the PAM sequence was reported, there was a weak correlation between the most efficient sgRNAs predicted by each study. This might underline the specificity of Cas9 activity in different systems and approaches, although some rules, such as the G-rich upstream of the PAM sequence, are widely applicable.
By testing 1280 sgRNAs in vivo using zebrafish embryos as a model system, we recapitulated the biases of the CRISPR-Cas9 system described above and uncovered specific features of efficient sgRNAs. We integrated these features into the CRISPRscan model, which we also validated in Xenopus (Moreno-Mateos et al. 2015) . In addition, because we directly provided in vitro-transcribed sgRNAs, we were able to identify features associated with sgRNA stability that correlate with stronger activities. Recent studies of chemically modified sgRNAs have shown that more stable sgRNAs are more active in primary human cells (Hendel et al. 2015) . These results highlight that the stability of the sgRNA molecule influences sgRNA activity when the sgRNA is exogenously provided rather than endogenously transcribed. Alternatively, differential stability influencing sgRNA activity may be controlled through delivery of preassembled Cas9-sgRNA ribonucleoprotein complexes (Gagnon et al. 2014; Kim et al. 2014) .
EXPANDING THE TARGETING REPERTOIRE
Apart from the predicted targeting efficiency, precise mutagenesis is limited by the frequency of the specific PAM in the targeted genome and the sequence constraints to produce the sgRNA. The adapted CRISPR-Cas9 system used most extensively today for gene targeting is based on the Type II CRISPR-Cas9 system from Streptococcus pyogenes (Cong et al. 2013; Jinek et al. 2013; Mali et al. 2013) . The Type II endonuclease Cas9 from these bacteria recognizes a PAM sequence next to the target consisting of 5 ′ -NGG ( Fig. 1 ). In addition, sgRNA sequences are further limited by their transcription requirements: sgRNAs require either (i) a G at the 5 ′ end of the molecule when using ex vivo RNA polymerase III-based systems or (ii) GA/GG when produced in vitro with SP6 or T7/T3 promoters. These restrictions limit the number of potential targets in the genome to 5 ′ -G[N 20 ]GG in the case of RNA polymerase III-based systems and to 5 ′ -G[G/A][N 19 ]GG for in vitro-transcribed sgRNAs.
To circumvent this constraint, various approaches have been recently developed. First, Cas9 orthologs from other bacteria (Neisseria meningitidis, Streptococcus thermophilus, and Staphylococcus aureus) have also been shown to target eukaryotic genomes Hou et al. 2013; Ran et al. 2015) . However, these orthologous Cas9s have PAM sequences longer or similar to those of S. pyogenes (e.g., S. aureus PAM: 5 ′ -NNGRRT), which do not dramatically increase the number of targets in a genome. To overcome this limitation, Kleinstiver et al. (2015) engineered the S. pyogenes Cas9 to recognize different PAM sequences (5 ′ -NGA and 5 ′ -NGCG), doubling the number of the targets in the human genome. More recently, a new endonuclease named Cpf1 was characterized , providing a significant increase in the number of genomic targets due to a drastically different PAM sequence (5 ′ -TTTN). As a complementary approach, we performed a large-scale analysis in which we sought efficient sgRNAs that target sequences other than the canonical G[G/A][N 19 ]GG (Moreno-Mateos et al. 2015) . We analyzed the activity of 11 alternative targeting formulations in zebrafish embryos, varying the lengths of the sgRNAs, and introducing mismatches to the first two nucleotides of the target site (Fig. 2) . We found that sgRNAs truncated by 1 or 2 nt or containing one mismatch in the first two positions of the sgRNA binding sequence were efficient alternatives to canonical sgRNAs, increasing the number of targets in the zebrafish genome by eightfold (Moreno-Mateos et al. 2015) . Notably, the activities of truncated sgRNAs are similar to those of canonical sgRNAs in ex vivo systems as well (Fu et al. 2014) , supporting the use of shorter sgRNAs for genome editing in vivo.
CONCLUDING REMARKS
The CRISPR-Cas9 system has revolutionized gene targeting and genome engineering. However, using it at its full potential requires optimizations and instructions on how to apply it. In this introduction, we have reviewed two improvements that allow researchers to select the most active and convenient sgRNAs: optimization of sgRNA targeting efficiency and expansion of the potential targets in the genome. Both optimizations have been integrated into our protocol for in vivo genome targeting and can be found in CRISPRscan; see Protocol: Optimized CRISPR-Cas9 System for Genome Editing in Zebrafish (Vejnar et al. 2016) .
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